Cochrane Abstracts
Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Multiple Versus Single Doses of Exogenous Surfactant for the Prevention or Treatment of Neonatal Respiratory Distress Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/Multiple_versus_single_doses_of_exogenous_surfactant_for_the_prevention_or_treatment_of_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review.
Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/Multiple_versus_single_doses_of_exogenous_surfactant_for_the_prevention_or_treatment_of_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review. Accessed November 12, 2025.
Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/Multiple_versus_single_doses_of_exogenous_surfactant_for_the_prevention_or_treatment_of_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review
Multiple Versus Single Doses of Exogenous Surfactant for the Prevention or Treatment of Neonatal Respiratory Distress Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 November 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/Multiple_versus_single_doses_of_exogenous_surfactant_for_the_prevention_or_treatment_of_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome
ID - 433271
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433271/0/Multiple_versus_single_doses_of_exogenous_surfactant_for_the_prevention_or_treatment_of_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
